Bellevue Group AG

Position in ALKS — Alkermes plc.

CIK 1674546 Zurich, V8

Position in ALKS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,300,733

+$5,987,090 QoQ

Shares Held

120,243

+1255.6% QoQ

Ownership

0.072%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#111

of 421 holders

Holding Since

Mar 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bellevue Group AG holds $124,492,646 across 6 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	188,515	$102,143,081
2	TEVA	Teva Pharmaceutical Industries Ltd	345,899	$11,719,058
3	ALKS	Alkermes plc. This page	120,243	$6,300,733
4	NBIX	Neurocrine Biosciences Inc	24,037	$4,051,195
5	VTRS	Viatris Inc	15,778	$250,554
6	ZTS	Zoetis Inc.	390	$28,025

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,300,733	120,243	+1255.6%	Shares	Defined	2026-08-14
2026-03-31	$313,643	8,870	+34.5%	Shares	Defined	2026-05-15
2025-12-31	$184,500	6,594	0.0%	Shares	Defined	2026-02-17
2025-09-30	$197,820	6,594	-63.4%	Shares	Defined	2025-11-14
2024-06-30	$433,800	18,000	-25.4%	Shares	Defined	2024-08-14
2024-03-31	$653,578	24,144	-53.7%	Shares	Defined	2024-05-15
2023-12-31	$1,445,586	52,112	-36.2%	Shares	Defined	2024-02-14
2023-09-30	$2,288,417	81,700	0.0%	Shares	Defined	2023-11-14
2023-06-30	$2,557,210	81,700	+27.3%	Shares	Defined	2023-08-14
2023-03-31	$1,809,798	64,200	+80.8%	Shares	Defined	2023-05-15
2022-12-31	$927,615	35,500	-66.9%	Shares	Defined	2023-02-14
2022-06-30	$3,193,488	107,200	+42.9%	Shares	Defined	2022-08-11
2022-03-31	$1,973,250	75,000	—	Shares	Defined	2022-05-13
No filing history on record for this holder in this stock.